Subsequent Events - Business Acquisitions

6 Months Ended

Jun. 30, 2013

Subsequent Events- Business Acquisitions

Subsequent Events - Business Acquisitions

Note 13 — Subsequent Events — Business Acquisitions

In July 2013, Abbott announced that it entered into agreements to acquire IDEV Technologies and OptiMedica.  The acquisition of IDEV Technologies will expand Abbott’s endovascular portfolio and the acquisition of OptiMedica will provide Abbott with an immediate entry point into the laser assisted cataract surgery market.  Under the terms of the agreement, Abbott will acquire all of the outstanding equity of IDEV Technologies for $310 million, net of cash and debt held by IDEV. Under the terms of the agreement, Abbott will acquire OptiMedica for $250 million in cash, net of cash held by OptiMedica, plus additional payments totaling up to $150 million upon completion of certain development, regulatory and sales milestones.